A recent study using a mouse model of burn injury and sepsis has shown that Flt3L treatment mitigates T cell depletion, restores CD28 expression on CD4+ and CD8+ T cells, and increases IFN-γ production by CD8+ T cells, thereby reducing organ injury markers and enhancing survival (122). This evidence concerns the gene CD4 and Sepsis.